VCYT
Veracyte, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.53
−4.79%Margins
Gross margin
72.1%
EBITDA margin
23.1%
EBIT margin
17.0%
Net margin
20.4%
FCF margin
29.4%
8.2%
Return on equity
7.7%
Return on assets
6.7%
Return on invested capital
0.38x
Asset turnover
$178.4M
Cash from operations
$6.04
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026